Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.
Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Ajman, AE · Author affiliation
Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.Location evidence
Shaqra, SA · Author affiliation
Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.Location evidence
Abha, SA · Author affiliation
Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.Location evidence
RU · Author affiliation · country only
Department of General Chemistry, Bashkir State Medical University, Ufa, Russia.Location evidence
Chicago, US · Author affiliation
Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL, United States.Location evidence
Publication status: correction_notice
A plain-language reading has not been prepared for this paper yet.
Original abstract
[This corrects the article DOI: 10.3389/fncel.2025.1681891.].